John W. Frew

Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: an EB-specific quality of life instrument

John W. Frew, Linda K. Martin, Tamar Nijsten et al. · British Journal of Dermatology · 2009 · 184 citations

Pharmacy, Dermatology, Epidemiology +16

Critical role of c-jun (NH2) terminal kinase in paracetamol- induced acute liver failure

Neil C. Henderson, K. J Pollock, John W. Frew et al. · Gut · 2006 · 184 citations · Full text

Pharmacy, Pharmacology, Toxicology +17

Epithelialized tunnels are a source of inflammation in hidradenitis suppurativa

Kristina Navrazhina, John W. Frew, Patricia Gilleaudeau et al. · Journal of Allergy and Clinical Immunology · 2021 · 129 citations · Full text

Veterinary Medicine, Pathology, Immunopathology +6

The effect of subcutaneous brodalumab on clinical disease activity in hidradenitis suppurativa: An open-label cohort study

John W. Frew, Kristina Navrazhina, David Grand et al. · Journal of the American Academy of Dermatology · 2020 · 115 citations · Full text

Medicine, Dermatology, Immunology +11

A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa

Supriya S. Venugopal, Wenfei Yan, John W. Frew et al. · Journal of the American Academy of Dermatology · 2013 · 113 citations

Medicine, Dermatology, Pathology +7